Surface Oncology to Participate in the 2023 Guggenheim
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......
Premiere Synthetic Biology Event on Track for Record
SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO,......
Envision Pharma Group Hires Leading Industry Executives
PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of two senior executives while further......